
Why This Chinese Biotech Could Be Pharma's DeepSeek
The drugmaker's shares rallied after the release of its strong annual report, up by a cumulative 18% over the next three trading days Key Takeaways: Akeso's drug sales rose 25% last year to just above 2 billion yuan, setting a new high for the …